WO2012168770A1 - Process for ozonization of a vegetable oil - Google Patents
Process for ozonization of a vegetable oil Download PDFInfo
- Publication number
- WO2012168770A1 WO2012168770A1 PCT/IB2011/055394 IB2011055394W WO2012168770A1 WO 2012168770 A1 WO2012168770 A1 WO 2012168770A1 IB 2011055394 W IB2011055394 W IB 2011055394W WO 2012168770 A1 WO2012168770 A1 WO 2012168770A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- ozonization
- ozonized
- ozone
- olive oil
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 67
- 238000006385 ozonation reaction Methods 0.000 title claims abstract description 53
- 230000008569 process Effects 0.000 title claims abstract description 51
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 31
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 30
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 36
- 239000003921 oil Substances 0.000 claims description 35
- 235000019198 oils Nutrition 0.000 claims description 35
- 239000010462 extra virgin olive oil Substances 0.000 claims description 31
- 235000021010 extra-virgin olive oil Nutrition 0.000 claims description 28
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 15
- 235000008390 olive oil Nutrition 0.000 claims description 10
- 239000004006 olive oil Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 239000011719 vitamin A Substances 0.000 claims description 9
- 235000019155 vitamin A Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 230000001575 pathological effect Effects 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 4
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 3
- 206010000496 acne Diseases 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 2
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 231100000397 ulcer Toxicity 0.000 claims description 2
- 239000000047 product Substances 0.000 description 34
- 150000002978 peroxides Chemical class 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 6
- 239000005642 Oleic acid Substances 0.000 description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- WURFKUQACINBSI-UHFFFAOYSA-M ozonide Chemical compound [O]O[O-] WURFKUQACINBSI-UHFFFAOYSA-M 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 238000005949 ozonolysis reaction Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- -1 nonanal aldehyde Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/006—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by oxidation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
Definitions
- the present invention relates to a process for ozonization of a vegetable oil, particularly extra virgin olive oil, to an ozonized oil obtainable with said process, to a composition that comprises it, optionally further comprising vitamin A and/or E, and to said composition for use in therapeutic treatments.
- the ozonization of vegetable oils is a long-known process; it is in fact disclosed in 191 1 in a first patent in the United States (US 984,722). Such document reports the ozonization of coconut oil by using medical oxygen at a temperature above 28 °C, and the process ends when a concentration of ozone of 0.5 mg in 1 ml of oil is reached. Use of the preparation thus obtained to treat nasal infections is reported. Subsequently, other patents were issued, again in the United States, regarding the ozonization of other vegetable oils, including olive oil (US 2,356,062), in which the olive oil is ozonized until it reaches a quantity of ozone equal to 1.85%. Use of the preparation thus obtained to fight skin and mucous membrane infections supported by bacteria and fungi is reported.
- Beal discloses the process of ozonization of an emulsion of water, soybean oil and pelargonaldehyde, performed in an autoclave (at a temperature between 70 and 100 °C) and under continuing agitation. The ozonization reaction is then followed by a reduction with hydrogen, and a compound that is very rich in aldehydes (i.e., ozonides) is thus obtained (US 3,504,038).
- Otsuki and Maggiolo too, describe the ozonization of vegetable oils emulsified with large quantities of water (US 2,862,940 and US 2,865,937).
- DeVillez discloses a method for ozonizing jojoba oil, in which the ozone was bubbled through a porous glass disk at a temperature of 50 °C, in this case again until saturation was reached.
- Use of the resulting preparation to treat acne is reported (US 4,591 ,602, 1986).
- Washuettl and Viebahn also ozonize oil to saturation in order to allow longer preservation.
- the process that they patented performs an extraction in an acid environment and in the presence of a redox system, in order to separate and isolate the short-chain aldehydes from the ozonized oil.
- the authors indicate that the best substrate for this procedure is olive oil (US 5, 183,91 1 ).
- Gomez et al. developed a product formed by a mix of ozonized vegetable oils enriched with lipoic acid, vitamins, essential amino acids and other components, which is indicated for treatment of gastroduodenal ulcers and as a food supplement (WO 01/37829 Al , EP1273295 Al ).
- the heat is utilized to improve the efficiency of the ozonization, because it induces a higher motility of the molecules and this increases the likelihood that the ozone molecules might collide with the fatty acid molecules, causing their lysis, which then generates ozonide formation.
- the most important difficulty observed in these methods is the low stability of the compounds obtained by ozonization, which does not allow long-term preservation of the product, since after a few months it loses its biological and antimicrobial properties. For this reason, in recent years some documents describe method which are supplement to ozonization, such as the use of ultrasound. Some documents describe the ozonization of vegetable oil emulsified with water; in this manner, a higher number of aldehydes is obtained. US 2006/0074129 Al ozonizes an emulsion of water and cocoa butter, obtaining a compound which is stable and rich in hydroxyaldehyde, the use of which is reported for treating several pathological conditions.
- the high temperature causes a chaotic distribution of the chains in the molecular structure of the ozonides, generating an unstable system characterized by internal tensions, which add to those caused by the steric hindrance of the ozonides.
- the authors use a redox system that converts the ozonides into peroxides, which are much more stable, since they have a lower steric hindrance and low internal tensions.
- the problem thus remains of providing a process for preparing, efficiently and without the addition of further oxidants, an ozonized derivative of a vegetable oil that is stable over time for long periods and can be used for example in a pharmaceutical formulation.
- the aim of the present invention is to provide a process for ozonizing a vegetable oil that does not suffer the disadvantages of the background art.
- an object of the present invention is to provide a composition that comprises or consists of ozonized vegetable oil that is useful as a medication.
- the aim and object of the invention are also achieved by means of an ozonized vegetable oil, particularly an ozonized extra virgin olive oil, that can be obtained by means of said process.
- the aim and object of the invention are also achieved by means of a composition comprising the ozonized vegetable oil according to said process and optionally at least one compound selected from vitamin A, vitamin E and mixtures thereof, and by a pharmaceutical composition comprising the ozonized vegetable oil according to said process or said composition optionally comprising vitamin A and/or E and by its use as a medication.
- the vegetable oil is preferably an olive oil, more preferably extra virgin olive oil and even more preferably extra virgin olive oil originating from the Salento area, particularly extra virgin olive oil of the Salento area obtained from Ogliarola leccese or Cellina di Nardo cultivars or mixtures thereof.
- Vegetable oils are chemically composed of triglycerides in which saturated and unsaturated fatty acids are present and the ozone binds with the unsaturated ones; the higher the content of unsaturated fatty acids of the vegetable oil, the higher the quantity of ozone that is trapped.
- the reaction of the ozone with the fatty acids that are present in extra virgin olive oil leads to the formation of new molecules, such as ozonides, aldehydes and carboxylic molecules, according to the Criegee mechanism (illustrated in the following scheme).
- unstable primary ozone ( 1 ) is an intermediate step of very short duration. A much more stable ozonide is obtained by settling. Molecules of fatty acids (ozonides) are thus formed in which the double bond is saturated by the tree oxygen atoms (2), trapping it and keeping it stable, making it available and ready for use for topical applications.
- the method according to the invention allows to obtain a product of high quality that is stable over time.
- the low temperatures and the magnetic field in addition to improving the efficiency of the production process, allow to shorten processing times and consequently to lower production costs.
- the product obtained with the method according to the invention is characterized by well-defined chemical parameters, which demonstrate and ensure the effectiveness of the ozonization procedure.
- an ozonized oil is obtained that has the appearance of a gel with an ozone saturation between 60% and 70% and can be used directly on the skin.
- the peroxide number (determined by reaction with I and titration with sodium thiosulphate 0.01 N) of the product obtained at the end of the ozonization procedure according to the present invention is comprised between 600 and 800 meq, and this indicates the high quality of the ozonized oil obtained.
- the finished product is collected in containers which are kept at a temperature between 1 and 6 °C, preferably at 4 °C.
- the containers are preferably made of dark glass to preserve it from interactions with light and are provided with a screw cap.
- the ozonization process according to the invention can be performed inside a thermostat-controlled chamber, at a temperature between 2 and 6 °C, preferably around 4 °C.
- the magnetic field applied in the method according to the invention is a magnetic field between 8 and 12 mT, preferably 10 mT, and is of the pulsed type with a frequency of 13- 130 Hz, preferably 72 Hz, generated for example by an apparatus manufactured by TWIN CEMP S.R.L.
- the ozone concentration in said gaseous mix is comprised between 8 mg/1 and 20 mg/1.
- a flow of ozone or gaseous mix containing ozone is used which is comprised between 300 and 700 1/h.
- the pressure inside said reactor is comprised between 0.2 and 1 bar. More preferably, the ozonization procedure is performed at 4 °C. In one aspect of the invention, the ozonization process according to the invention is applied to the extra virgin olive oil obtained from cultivars of the Salento area.
- the present invention relates to the ozonized extra virgin olive oil obtained by using the process according to the invention starting from extra virgin olive oil obtained from the Salento cultivars Ogliarola leccese, Cellina di Nardo and mixtures thereof.
- the best yield in the ozonization process was obtained by using extra virgin olive oil composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil.
- Bioxoil has a 98% triglyceride content and 2% of minor constituents having a biological action (polyphenols).
- the ozonization process according to the invention reduces considerably the triglyceride content (less than 50%) and leads to the formation of many compounds (ozonides), especially nonanal aldehyde and nonanoic acid, which contain active oxygen and are responsible for many of the biological activities of Bioxoil.
- the oil subjected to ozonization is extra virgin oil which is composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil, the applied magnetic field is 10 mT and has a frequency of 72 Hz, the ozonization temperature is 4 °C and the preservation temperature is 4 °C.
- the invention relates to a composition
- a composition comprising a vegetable oil ozonized with the method according to the present invention, particularly an extra virgin olive oil of Salento cultivars, preferably originating from the Salento cultivars Cellina di Nardo and Ogliarola leccese, to which vitamins A and/or E are optionally added at the end of the transformation.
- the present invention relates to a pharmaceutical composition which comprises or consists of the ozonized vegetable oil according to the invention, comprising the treatment of the vegetable oil with ozone in the presence of a pulsed magnetic field and at a temperature comprised between 2 and 6 °C.
- the vegetable oil ozonized with the method according to the present invention is a product for topical use having a plurality of biological properties which are due to the emollient and antioxidant properties of olive oil and to the antimicrobial properties of ozone.
- the results of the research conducted demonstrate that this oil or Bioxoil has a marked antimicrobial and fungicidal activity and an extremely low cytotoxocity.
- vitamins A and/or E which have known beneficial properties on the skin
- vitamins A and/or E which have known beneficial properties on the skin
- vitamin A helps in soothing inflammations and prevents skin aging, stimulating cell renewal
- vitamin E tocopherol
- Said product thus obtained characterized by a large peroxide number, by excellent stability over time and by a gradual and long release of ozone once it has been applied to the skin, can be not only an excellent low-cost product to be used in pharmacy and parapharmacy, but also an extremely valid alternative to ozone therapy, which is used currently in medicine for therapeutic purposes.
- Clinical ozone therapy is used to treat many types of pathological conditions, from infections to ischemias to neurodegenerative disorders, and consists in injecting ozone, in gaseous form or dissolved in pyrogen-free water, intravenously/arterial ly, endopleurally, intraperitoneally, et cetera.
- Ozone therapy is an excellent type of therapy that is often resolutive, even though it has many limiting factors. First of all, it cannot be performed at home, but the patient must go to the medical center, where he/she must be monitored also due to the risk of possible embolisms, it is invasive and often painful, and therapeutic cycles are composed of numerous sessions and it is also expensive.
- the product according to the invention optionally after the addition of vitamin A and/or E, preferably A and E, can be an excellent replacement of conventional ozone therapy for pathological conditions of the skin, since the patient could apply the ozonized oil himself/herself, in his/her own home, without risks and certainly reducing considerably the health costs.
- said pharmaceutical composition comprises or consists of extra virgin olive oil ozonized by means of said process.
- said olive oil is extra virgin olive oil obtained from the Ogliarola leccese and Cellina di Nardo cultivars.
- said composition comprises an oil obtained by ozonization of extra virgin olive oil composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil, in the presence of an applied magnetic field of 10 mT pulsed at a frequency of 72 Hz, at an ozonization temperature of 4 °C and optionally preserved at a storage temperature of 4 °C, and with the addition of vitamin A and E.
- said pharmaceutical composition is in a formulation for topical use.
- the present invention relates to said pharmaceutical composition for use as a medication.
- the present invention relates to said pharmaceutical composition for use in the treatment or prevention of at least one pathological condition selected from bedsores, ulcers, mycoses and onichomycoses, labial herpes, aphthae, acne, atypical dermatitides or psoriases.
- a quantity of extra virgin olive oil which is an extra virgin olive oil composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil, equal to 100 ml, placed inside a glass cylinder wrapped with tin foil to prevent light from penetrating, is subjected to an ozonization process for 8 hours, with the application of a magnetic field with an intensity of 10 mT, pulsed with a frequency of 72 Hz at a temperature of 4 °C.
- a porous ceramic cylinder is provided which measured 2 cm in length and 1 cm in diameter and is connected, by means of a PVC tube with a diameter of 0.5 cm, to the ozone generator.
- the flow of ozonized air inside the oil is approximately 400 liters/hour and is propelled with a pressure of 0.2 bars.
- Such a high gas flow is adopted because this allows to reduce the concentration of the more volatile compounds when they are made to flow out of the reactor during the ozonization process.
- the high flow of gas makes the distribution and diffusion of said ozone inside the oil more uniform.
- composition of the resulting ozonized product was determined by gas chromatography and is given in Table 1 by comparison with the composition of the same oil prior to ozonization.
- Example 1 was repeated without applying the magnetic field and at a temperature of 25°C.
- composition of the resulting ozonized product was determined by gas chromatography and is given in Table 3 in comparison with the composition of the product of Example 1.
- the acidity index, the peroxide number and the iodine number of the resulting product were determined immediately after ozonization and are given in Table 4 together with the same parameters determined after the ozonized product had been stored for 6 months at 25 °C.
- Example 1 was repeated by using a non-Salento extra virgin olive oil, i.e., Cima di Bitonto.
- the composition of the resulting ozonized product was determined by gas chromatography and is given in Table 3 in comparison with the composition of the product of Example 1. It can be noted that the Salento extra virgin olive oil subjected to the ozonization process according to the invention yields a higher quantity of peroxides and ozonides than other extra virgin olive oils subjected to the same treament, and this gives the product advantageous characteristics.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A process for the ozonization of a vegetable oil, the product obtained with the process and the compositions that contain it.
Description
PROCESS FOR OZONIZATION OF A VEGETABLE OIL
Technical field
The present invention relates to a process for ozonization of a vegetable oil, particularly extra virgin olive oil, to an ozonized oil obtainable with said process, to a composition that comprises it, optionally further comprising vitamin A and/or E, and to said composition for use in therapeutic treatments.
Background art
The ozonization of vegetable oils is a long-known process; it is in fact disclosed in 191 1 in a first patent in the United States (US 984,722). Such document reports the ozonization of coconut oil by using medical oxygen at a temperature above 28 °C, and the process ends when a concentration of ozone of 0.5 mg in 1 ml of oil is reached. Use of the preparation thus obtained to treat nasal infections is reported. Subsequently, other patents were issued, again in the United States, regarding the ozonization of other vegetable oils, including olive oil (US 2,356,062), in which the olive oil is ozonized until it reaches a quantity of ozone equal to 1.85%. Use of the preparation thus obtained to fight skin and mucous membrane infections supported by bacteria and fungi is reported.
In 1970, Beal discloses the process of ozonization of an emulsion of water, soybean oil and pelargonaldehyde, performed in an autoclave (at a temperature between 70 and 100 °C) and under continuing agitation. The ozonization reaction is then followed by a reduction with hydrogen, and a compound that is very rich in aldehydes (i.e., ozonides) is thus obtained (US 3,504,038). In previously published documents, Otsuki and Maggiolo, too, describe the ozonization of vegetable oils emulsified with large quantities of water (US 2,862,940 and US 2,865,937).
Other patents disclose the ozonization of vegetable oils (corn, olive and sesame); in particular, US 4,451 ,480 ( 1984) discloses the ozonization of these oils to saturation, i.e., when all the double bonds of the fatty acids
have broken to bind the ozone.
Subsequently, DeVillez discloses a method for ozonizing jojoba oil, in which the ozone was bubbled through a porous glass disk at a temperature of 50 °C, in this case again until saturation was reached. Use of the resulting preparation to treat acne is reported (US 4,591 ,602, 1986).
Washuettl and Viebahn also ozonize oil to saturation in order to allow longer preservation. After ozonization, the process that they patented performs an extraction in an acid environment and in the presence of a redox system, in order to separate and isolate the short-chain aldehydes from the ozonized oil. The authors indicate that the best substrate for this procedure is olive oil (US 5, 183,91 1 ).
Two Russian patents (RU2040235A, RU 2131673C 1 ) disclose the use of low-frequency ultrasound combined with the ozonization process. In this manner, the resulting product, again brought to saturation with ozone (peroxide number higher than 1000 meq), is stable for six months, keeping its antibacterial properties unchanged.
Recently, Gomez et al. developed a product formed by a mix of ozonized vegetable oils enriched with lipoic acid, vitamins, essential amino acids and other components, which is indicated for treatment of gastroduodenal ulcers and as a food supplement (WO 01/37829 Al , EP1273295 Al ).
Generally, several processes for obtaining ozonized vegetable oils are described and they all have the common characteristics that the ozonization process is performed up to oil saturation, no additives or solvents are added, and medical oxygen is used to produce the ozone. Moreover, all the ozonization process disclosed in the patents are characterized in that operations occur at ambient temperature or often at temperatures above 50 °C. The temperature increase is a spontaneous process during ozonization, because the ozonolysis reaction is exothermic, and is often used as a parameter to monitor the behavior of the process. The heat is utilized to
improve the efficiency of the ozonization, because it induces a higher motility of the molecules and this increases the likelihood that the ozone molecules might collide with the fatty acid molecules, causing their lysis, which then generates ozonide formation. The most important difficulty observed in these methods is the low stability of the compounds obtained by ozonization, which does not allow long-term preservation of the product, since after a few months it loses its biological and antimicrobial properties. For this reason, in recent years some documents describe method which are supplement to ozonization, such as the use of ultrasound. Some documents describe the ozonization of vegetable oil emulsified with water; in this manner, a higher number of aldehydes is obtained. US 2006/0074129 Al ozonizes an emulsion of water and cocoa butter, obtaining a compound which is stable and rich in hydroxyaldehyde, the use of which is reported for treating several pathological conditions.
In other documents (e.g., WO2007046122), in order to accelerate the ozonization reaction, a catalyst such as iron sulfate is used which, by acting as an electron donor, reacts rapidly with the ozone, forming the anion radical of ozone 03 ", which is more reactive than ozone itself against double bonds of fatty acids. However, it has been observed that in this manner the produced ozonides are extremely unstable and therefore the ozonized oil keeps for a limited period (a few days) and it has been hypothesized that the heat generated by the reaction, which is necessary for the reaction to proceed, at the same time causes the instability of the ozonides. The high temperature causes a chaotic distribution of the chains in the molecular structure of the ozonides, generating an unstable system characterized by internal tensions, which add to those caused by the steric hindrance of the ozonides. To stabilize the system, the authors use a redox system that converts the ozonides into peroxides, which are much more stable, since they have a lower steric hindrance and low internal tensions. Once the ozonization reaction has ended, alpha lipoic acid, a powerful antioxidant, is
added to the product and reacts with the ozonides, leading to the formation of peroxides. In this manner a product is obtained that is reported to be stable over time.
The problem thus remains of providing a process for preparing, efficiently and without the addition of further oxidants, an ozonized derivative of a vegetable oil that is stable over time for long periods and can be used for example in a pharmaceutical formulation.
Summary of the invention
The aim of the present invention is to provide a process for ozonizing a vegetable oil that does not suffer the disadvantages of the background art.
Within this aim, an object of the present invention is to provide a composition that comprises or consists of ozonized vegetable oil that is useful as a medication.
This aim and these and other objects that will become better apparent hereinafter are achieved by means of a process for the ozonization of a vegetable oil, comprising the treatment of the vegetable oil with ozone or a gaseous mix comprising ozone in a reactor in the presence of a pulsed magnetic field and at a temperature comprised between 2 and 6 °C.
The aim and object of the invention are also achieved by means of an ozonized vegetable oil, particularly an ozonized extra virgin olive oil, that can be obtained by means of said process.
The aim and object of the invention are also achieved by means of a composition comprising the ozonized vegetable oil according to said process and optionally at least one compound selected from vitamin A, vitamin E and mixtures thereof, and by a pharmaceutical composition comprising the ozonized vegetable oil according to said process or said composition optionally comprising vitamin A and/or E and by its use as a medication.
Ways of carrying out the invention
The vegetable oil is preferably an olive oil, more preferably extra
virgin olive oil and even more preferably extra virgin olive oil originating from the Salento area, particularly extra virgin olive oil of the Salento area obtained from Ogliarola leccese or Cellina di Nardo cultivars or mixtures thereof.
Vegetable oils are chemically composed of triglycerides in which saturated and unsaturated fatty acids are present and the ozone binds with the unsaturated ones; the higher the content of unsaturated fatty acids of the vegetable oil, the higher the quantity of ozone that is trapped. The reaction of the ozone with the fatty acids that are present in extra virgin olive oil leads to the formation of new molecules, such as ozonides, aldehydes and carboxylic molecules, according to the Criegee mechanism (illustrated in the following scheme).
The formation of unstable primary ozone ( 1 ) is an intermediate step of very short duration. A much more stable ozonide is obtained by settling. Molecules of fatty acids (ozonides) are thus formed in which the double
bond is saturated by the tree oxygen atoms (2), trapping it and keeping it stable, making it available and ready for use for topical applications.
It has been found surprisingly that with the ozonization process of the invention, which is characterized by the application of a pulsed magnetic field and of low temperatures, it is possible to obtain a product of higher quality than the same oil subjected to ozonization (for the same time and in the same quantity) without applying the magnetic field and the low temperature.
In the case of the ozonization of olive oil, it has been found that the percentage of oleic acid in oil ozonized in the absence of magnetic field and at ambient temperature is higher than the percentage of oleic acid in olive oil ozonized with the process according to the invention, which indicates a higher efficiency of the process according to the present invention.
This means that with the ozonization procedure according to the invention, with respect to the methods of the background art, a larger number of fatty acid molecules (the most abundant of which is oleic acid) are attacked by the ozone, with consequent production of a larger quantity of ozonides.
The method according to the invention allows to obtain a product of high quality that is stable over time. The low temperatures and the magnetic field, in addition to improving the efficiency of the production process, allow to shorten processing times and consequently to lower production costs.
The product obtained with the method according to the invention is characterized by well-defined chemical parameters, which demonstrate and ensure the effectiveness of the ozonization procedure.
With this process, therefore, an ozonized oil is obtained that has the appearance of a gel with an ozone saturation between 60% and 70% and can be used directly on the skin.
The peroxide number (determined by reaction with I and titration
with sodium thiosulphate 0.01 N) of the product obtained at the end of the ozonization procedure according to the present invention is comprised between 600 and 800 meq, and this indicates the high quality of the ozonized oil obtained.
Preferably, at the end of the ozonization process, the finished product is collected in containers which are kept at a temperature between 1 and 6 °C, preferably at 4 °C. The containers are preferably made of dark glass to preserve it from interactions with light and are provided with a screw cap. The ozonization process and the subsequent preservation of the product at low temperatures allows a better outcome of the transformation and higher stability during preservation.
After 12 months the peroxide number drops significantly, but nonetheless remains around 600 and 800 meq, which ensure the effectiveness of the ozonized oil in the several fields of application. The literature in fact reports that ozonized oil maintains an antimicrobial activity if it contains a peroxide number between 600 and 800 meq.
The ozonization process according to the invention can be performed inside a thermostat-controlled chamber, at a temperature between 2 and 6 °C, preferably around 4 °C.
The magnetic field applied in the method according to the invention is a magnetic field between 8 and 12 mT, preferably 10 mT, and is of the pulsed type with a frequency of 13- 130 Hz, preferably 72 Hz, generated for example by an apparatus manufactured by TWIN CEMP S.R.L.
Preferably, in the process according to the invention the ozone concentration in said gaseous mix is comprised between 8 mg/1 and 20 mg/1.
Preferably, in the process according to the invention, a flow of ozone or gaseous mix containing ozone is used which is comprised between 300 and 700 1/h.
Preferably, in the process according to the invention, the pressure inside said reactor is comprised between 0.2 and 1 bar.
More preferably, the ozonization procedure is performed at 4 °C. In one aspect of the invention, the ozonization process according to the invention is applied to the extra virgin olive oil obtained from cultivars of the Salento area. The characteristics of extra virgin olive oil obtained from cultivars of the Salento area {Cellina di Nardo and Ogliarola leccese) and ozonized with the process according to the present invention, termed Bioxoil herein, have been compared with those of other ozonized oils, and it has emerged that extra virgin olive oil of the Salento area subjected to the ozonization process according to the invention provides a higher quantity of peroxides and ozonides than other extra virgin olive oils subjected to the same treatment, which gives the product advantageous characteristics.
In one embodiment, the present invention relates to the ozonized extra virgin olive oil obtained by using the process according to the invention starting from extra virgin olive oil obtained from the Salento cultivars Ogliarola leccese, Cellina di Nardo and mixtures thereof.
Use of extra virgin olive oil obtained from the cultivars Ogliarola leccese, Cellina di Nardo and mixtures thereof as raw material allows to further reduce the processing times, since using this initial product higher quantities of ozonides are produced than other extra virgin olive oils.
The best yield in the ozonization process was obtained by using extra virgin olive oil composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil.
The Salento extra virgin olive oil used to develop the product according to the invention Bioxoil has a 98% triglyceride content and 2% of minor constituents having a biological action (polyphenols). The ozonization process according to the invention reduces considerably the triglyceride content (less than 50%) and leads to the formation of many compounds (ozonides), especially nonanal aldehyde and nonanoic acid, which contain active oxygen and are responsible for many of the biological activities of Bioxoil.
In a preferred embodiment, the oil subjected to ozonization is extra virgin oil which is composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil, the applied magnetic field is 10 mT and has a frequency of 72 Hz, the ozonization temperature is 4 °C and the preservation temperature is 4 °C.
In another aspect, the invention relates to a composition comprising a vegetable oil ozonized with the method according to the present invention, particularly an extra virgin olive oil of Salento cultivars, preferably originating from the Salento cultivars Cellina di Nardo and Ogliarola leccese, to which vitamins A and/or E are optionally added at the end of the transformation.
In one aspect, the present invention relates to a pharmaceutical composition which comprises or consists of the ozonized vegetable oil according to the invention, comprising the treatment of the vegetable oil with ozone in the presence of a pulsed magnetic field and at a temperature comprised between 2 and 6 °C.
The vegetable oil ozonized with the method according to the present invention, particularly Bioxoil, is a product for topical use having a plurality of biological properties which are due to the emollient and antioxidant properties of olive oil and to the antimicrobial properties of ozone. The results of the research conducted demonstrate that this oil or Bioxoil has a marked antimicrobial and fungicidal activity and an extremely low cytotoxocity.
The addition to the product obtained with the process according to the invention, particularly based on extra virgin olive oil and more preferably based on extra virgin olive oil obtained from Salento cultivars, of vitamins A and/or E, preferably A and E, which have known beneficial properties on the skin, provide particular characteristics and boost the therapeutic effectiveness of the product. In particular, vitamin A (retinol) helps in soothing inflammations and prevents skin aging, stimulating cell renewal,
while vitamin E (tocopherol) is antioxidant, and therefore its use is also useful to further stabilize the product.
Said product thus obtained, characterized by a large peroxide number, by excellent stability over time and by a gradual and long release of ozone once it has been applied to the skin, can be not only an excellent low-cost product to be used in pharmacy and parapharmacy, but also an extremely valid alternative to ozone therapy, which is used currently in medicine for therapeutic purposes.
Clinical ozone therapy is used to treat many types of pathological conditions, from infections to ischemias to neurodegenerative disorders, and consists in injecting ozone, in gaseous form or dissolved in pyrogen-free water, intravenously/arterial ly, endopleurally, intraperitoneally, et cetera.
Ozone therapy is an excellent type of therapy that is often resolutive, even though it has many limiting factors. First of all, it cannot be performed at home, but the patient must go to the medical center, where he/she must be monitored also due to the risk of possible embolisms, it is invasive and often painful, and therapeutic cycles are composed of numerous sessions and it is also expensive.
The product according to the invention, optionally after the addition of vitamin A and/or E, preferably A and E, can be an excellent replacement of conventional ozone therapy for pathological conditions of the skin, since the patient could apply the ozonized oil himself/herself, in his/her own home, without risks and certainly reducing considerably the health costs.
Preferably, said pharmaceutical composition comprises or consists of extra virgin olive oil ozonized by means of said process.
More preferably, in said pharmaceutical composition said olive oil is extra virgin olive oil obtained from the Ogliarola leccese and Cellina di Nardo cultivars.
Even more preferably, said composition comprises an oil obtained by ozonization of extra virgin olive oil composed of 70% Cellina di Nardo oil
and 30% Ogliarola leccese oil, in the presence of an applied magnetic field of 10 mT pulsed at a frequency of 72 Hz, at an ozonization temperature of 4 °C and optionally preserved at a storage temperature of 4 °C, and with the addition of vitamin A and E.
Preferably, said pharmaceutical composition is in a formulation for topical use.
In one aspect, the present invention relates to said pharmaceutical composition for use as a medication.
In one aspect, the present invention relates to said pharmaceutical composition for use in the treatment or prevention of at least one pathological condition selected from bedsores, ulcers, mycoses and onichomycoses, labial herpes, aphthae, acne, atypical dermatitides or psoriases.
The following examples illustrate in a non-limiting manner the possible methods of preparation:
EXAMPLES
Example 1
A quantity of extra virgin olive oil which is an extra virgin olive oil composed of 70% Cellina di Nardo oil and 30% Ogliarola leccese oil, equal to 100 ml, placed inside a glass cylinder wrapped with tin foil to prevent light from penetrating, is subjected to an ozonization process for 8 hours, with the application of a magnetic field with an intensity of 10 mT, pulsed with a frequency of 72 Hz at a temperature of 4 °C. Inside the cylinder, immersed in oil, a porous ceramic cylinder is provided which measured 2 cm in length and 1 cm in diameter and is connected, by means of a PVC tube with a diameter of 0.5 cm, to the ozone generator. The flow of ozonized air inside the oil is approximately 400 liters/hour and is propelled with a pressure of 0.2 bars. Such a high gas flow is adopted because this allows to reduce the concentration of the more volatile compounds when they are made to flow out of the reactor during the ozonization process.
Moreover, the high flow of gas makes the distribution and diffusion of said ozone inside the oil more uniform.
The composition of the resulting ozonized product was determined by gas chromatography and is given in Table 1 by comparison with the composition of the same oil prior to ozonization.
Table 1
The acidity index, the peroxide number and the iodine number of the resulting product were determined immediately after ozonization and are given in Table 2 together with the same parameters determined after the ozonized product had been stored for 12 months at 4 °C.
Table 2
Example 2 (for comparison)
Example 1 was repeated without applying the magnetic field and at a temperature of 25°C.
The composition of the resulting ozonized product was determined by gas chromatography and is given in Table 3 in comparison with the composition of the product of Example 1.
Table 3
The acidity index, the peroxide number and the iodine number of the resulting product were determined immediately after ozonization and are given in Table 4 together with the same parameters determined after the ozonized product had been stored for 6 months at 25 °C.
Table 4
The data presented in Table 3 in fact show that the percentage of oleic acid in Salento extra virgin olive oil obtained from Ogliarola leccese and Cellina di Nardo cultivars (the same one used to produce Bioxoil), ozonized at 25°C and without magnetic field, is approximately 57%, higher than Bioxoil (44.8%), indicating that the ozonization process performed at ambient temperature does not have a high efficiency. The verification of this is the percentages of the ozonides (especially nonanal and nonanoic acid) generated by ozonolysis of oleic acid, which are lower than those of Bioxoil. This means that with the ozonization process according to the invention, with respect to the methods of the background art, a larger number of fatty acid molecules (among which the most abundant is oleic acid) is attacked by the ozone, with consequent production of a larger quantity of ozonide.
Therefore, at ambient temperature the ozonization process, in the times and manners described above, and the subsequent preservation in fact do not ensure that the product acquire and keeps stable over time all the characteristics given above. It can in fact be noted that with ozonization and
preservation at 25°C the chemical parameter of the product are lower, which indicates a smaller quantity of ozone trapped by the fatty acid molecules and indicates instability of the product (Table 4).
Example 3
Example 1 was repeated by using a non-Salento extra virgin olive oil, i.e., Cima di Bitonto.
The composition of the resulting ozonized product was determined by gas chromatography and is given in Table 3 in comparison with the composition of the product of Example 1. It can be noted that the Salento extra virgin olive oil subjected to the ozonization process according to the invention yields a higher quantity of peroxides and ozonides than other extra virgin olive oils subjected to the same treament, and this gives the product advantageous characteristics.
The disclosures in Italian Patent Application no. MI201 1A001045, from which this application claims priority, are incorporated herein by reference.
Claims
1. A process for the ozonization of a vegetable oil, comprising the treatment of the vegetable oil with ozone or a gaseous mix comprising ozone in a reactor in the presence of a pulsed magnetic field and at a temperature comprised between 2 and 6 °C, obtaining an ozonized vegetable oil, and optionally the preservation of the ozonized vegetable oil at a temperature between 1 and 6 °C.
2. The process according to claim 1 , wherein the pulsed magnetic field has a frequency between 13 and 130 Hz.
3. The process according to claim 1 or 2, wherein the ozone concentration in said gaseous mix is comprised between 8 mg/1 and 20 mg/1 and optionally the flow is comprised between 300 and 700 1/h, and/or the pressure inside said reactor is comprised between 0.2 and 1 bar.
4. The process according to one of the preceding claims, wherein the vegetable oil is an olive oil, preferably an extra virgin olive oil, more preferably an extra virgin olive oil of a Salento cultivar.
5. The process according to claim 4, wherein the olive oil is an extra virgin olive oil obtained from the Ogliarola leccese and Cellina di Nardo cultivars.
6. An ozonized oil obtainable by means of the process according to one of claims 1-5.
7. A composition comprising an ozonized oil according to claim 6 and optionally at least one compound selected from vitamin A, vitamin E and mixtures thereof.
8. A pharmaceutical composition comprising or consisting of an ozonized oil according to claim 6 or of the composition according to claim
7.
9. The pharmaceutical composition according to claim 8 in a formulation for topical use.
10. The oil according to one of claims 1 to 6 or the composition
according to claim 8 or 9 for use in the treatment or prevention of at least one pathological condition selected from bedsores, ulcers, mycoses and onichomycoses, labial herpes, aphthae, acne, atypical dermatitides or psoriases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2011A001045 | 2011-06-10 | ||
IT001045A ITMI20111045A1 (en) | 2011-06-10 | 2011-06-10 | PROCEDURE FOR THE OZONIZATION OF A VEGETABLE OIL. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012168770A1 true WO2012168770A1 (en) | 2012-12-13 |
Family
ID=44555102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/055394 WO2012168770A1 (en) | 2011-06-10 | 2011-11-30 | Process for ozonization of a vegetable oil |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITMI20111045A1 (en) |
WO (1) | WO2012168770A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014015290A1 (en) | 2012-07-19 | 2014-01-23 | P2 Science, Inc. | Ozonolysis operations for generation of reduced and/or oxidized product streams |
ITBA20120052A1 (en) * | 2012-09-06 | 2014-03-07 | Guerra Lorenzo | "DEVICE FOR THE GASIFICATION OF A LIPID MATRIX IN ENVIRONMENT AT A CONTROLLED TEMPERATURE" |
ITBA20130010A1 (en) * | 2013-02-13 | 2014-08-14 | Alice Biosources Srl | COMPOSITION FOR COSMETIC USE INCLUDING OLIVE OXIDE |
ITMI20132112A1 (en) * | 2013-12-17 | 2015-06-18 | Pf S R L | COMPOSITION FOR THE TREATMENT OF MASTITIS IN COWS FROM MILK AND OVICAPRAPERS AND AN EQUIPMENT FOR THE PRODUCTION OF SUCH COMPOSITION. |
US9347014B2 (en) | 2013-04-03 | 2016-05-24 | Gfo Oil Llc | Methods and systems for generating aldehydes from organic seed oils |
ITUB20155024A1 (en) * | 2015-11-24 | 2017-05-24 | Dario Apuzzo | New nutraceutical composition, which can be administered orally, for the prevention or treatment of inflammatory and painful states of the upper airway. |
ITUB20156007A1 (en) * | 2015-11-30 | 2017-05-30 | S I P R E S S R L | PROCEDURE FOR THE PRODUCTION OF OZONIZED NATURAL OILS AND OZONIZED NATURAL OIL MADE WITH THIS PROCEDURE |
ES2646335A1 (en) * | 2016-06-10 | 2017-12-13 | Nicolás RUBIO GARCÍA | Ozoneized oil with antioxidants (Machine-translation by Google Translate, not legally binding) |
IT201700037319A1 (en) * | 2017-04-05 | 2018-10-05 | Moss S P A | NATURAL COMPOSITION FOR USE IN GYNECOLOGY |
WO2021105638A1 (en) | 2019-11-29 | 2021-06-03 | Demeta | Use of hydroperoxy alcohols and the derivatives thereof as antimicrobial agents |
EP3904327A1 (en) | 2020-04-30 | 2021-11-03 | Röhm GmbH | Method for the preparation of hydroxyalkyl-(meth) acrylic acid esters by oxidative cleavage of methacrolein acetals |
US11236289B2 (en) | 2017-11-22 | 2022-02-01 | Organicare, Llc | Method for the production of an ozonized olive oil |
EP3949980A1 (en) | 2020-08-04 | 2022-02-09 | Vassiliki Griva | Compositions for the treatment of atopic dermatitis containing ozonated oils and natural antioxidant agents |
FR3123208A1 (en) * | 2021-06-01 | 2022-12-02 | Demeta | Cosmetic use of a hydroperoxyalcohol to fight against the cutaneous signs of aging |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3900821B1 (en) * | 2020-04-20 | 2024-05-29 | Erbagil S.r.l. | Fixed or mobile device for the gasification of pure substances, homogeneous heterogeneous and colloidal, natural or synthetic, systems with oxygen-ozone mixtures at different concentrations, for different times, controlled temperature and pressure which leads to the formation of ozoyl, stable ozonides in products of their reaction |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US984722A (en) | 1909-05-14 | 1911-02-21 | Gerard Ozone Process Company | Composition yielding ozone. |
US2356062A (en) | 1942-02-03 | 1944-08-15 | Latimer Lab Inc | Therapeutic composition |
US2862940A (en) | 1952-11-27 | 1958-12-02 | Otsuki Hiroshi | Process for the production of omegaamino acids |
US2865937A (en) | 1956-03-06 | 1958-12-23 | Welsbach Corp | Processes for the production of dibasic and monobasic acids |
US3504038A (en) | 1966-06-24 | 1970-03-31 | Us Agriculture | Ozonization of vegetable oils in an improved aqueous medium |
US4451480A (en) | 1982-04-16 | 1984-05-29 | James Howard Brown | Method of treating acne using ozonized materials |
US4591602A (en) | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
US5183911A (en) | 1986-03-01 | 1993-02-02 | Dr. J. Hansler Gmbh | Process for the production of stable ozonized oils from unsaturated vegetable oils |
RU2040235C1 (en) | 1992-08-31 | 1995-07-25 | Владимир Германович Поздеев | Method for curing acute and chronic inflammation of middle ear |
RU2131673C1 (en) | 1998-04-17 | 1999-06-20 | Педдер Валерий Викторович | Method of preparing ozonized oil "otrisan" |
WO2001037829A1 (en) | 1999-11-25 | 2001-05-31 | Gomez Moraleda Manuel Antonio | Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine |
WO2006021924A1 (en) * | 2004-08-26 | 2006-03-02 | Pieter Josua Le Roux | Therapeutic oil from plant origine |
US20060074129A1 (en) | 2002-04-08 | 2006-04-06 | Mirabal Jesus M | Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
US20060153939A1 (en) * | 2003-02-14 | 2006-07-13 | Ordonez Jacome Neptali R C | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
WO2007046122A2 (en) | 2005-10-17 | 2007-04-26 | Bioo3Pharma S.R.L. | Ozonised oil, process for the preparation and use thereof in medical field |
WO2007137881A1 (en) * | 2006-06-01 | 2007-12-06 | Sano Medical Bvba | Wound care treatment product |
-
2011
- 2011-06-10 IT IT001045A patent/ITMI20111045A1/en unknown
- 2011-11-30 WO PCT/IB2011/055394 patent/WO2012168770A1/en active Application Filing
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US984722A (en) | 1909-05-14 | 1911-02-21 | Gerard Ozone Process Company | Composition yielding ozone. |
US2356062A (en) | 1942-02-03 | 1944-08-15 | Latimer Lab Inc | Therapeutic composition |
US2862940A (en) | 1952-11-27 | 1958-12-02 | Otsuki Hiroshi | Process for the production of omegaamino acids |
US2865937A (en) | 1956-03-06 | 1958-12-23 | Welsbach Corp | Processes for the production of dibasic and monobasic acids |
US3504038A (en) | 1966-06-24 | 1970-03-31 | Us Agriculture | Ozonization of vegetable oils in an improved aqueous medium |
US4451480A (en) | 1982-04-16 | 1984-05-29 | James Howard Brown | Method of treating acne using ozonized materials |
US4591602A (en) | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
US5183911A (en) | 1986-03-01 | 1993-02-02 | Dr. J. Hansler Gmbh | Process for the production of stable ozonized oils from unsaturated vegetable oils |
RU2040235C1 (en) | 1992-08-31 | 1995-07-25 | Владимир Германович Поздеев | Method for curing acute and chronic inflammation of middle ear |
RU2131673C1 (en) | 1998-04-17 | 1999-06-20 | Педдер Валерий Викторович | Method of preparing ozonized oil "otrisan" |
WO2001037829A1 (en) | 1999-11-25 | 2001-05-31 | Gomez Moraleda Manuel Antonio | Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine |
EP1273295A1 (en) | 1999-11-25 | 2003-01-08 | Manuel-Antonio Gomez Moraleda | Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine |
US20060074129A1 (en) | 2002-04-08 | 2006-04-06 | Mirabal Jesus M | Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
US20060153939A1 (en) * | 2003-02-14 | 2006-07-13 | Ordonez Jacome Neptali R C | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
WO2006021924A1 (en) * | 2004-08-26 | 2006-03-02 | Pieter Josua Le Roux | Therapeutic oil from plant origine |
WO2007046122A2 (en) | 2005-10-17 | 2007-04-26 | Bioo3Pharma S.R.L. | Ozonised oil, process for the preparation and use thereof in medical field |
WO2007137881A1 (en) * | 2006-06-01 | 2007-12-06 | Sano Medical Bvba | Wound care treatment product |
Non-Patent Citations (3)
Title |
---|
ANON: "The extra virgin olive oil ozonated Pugliese", 18 January 2010 (2010-01-18), pages 1 - 3, XP002670094, Retrieved from the Internet <URL:http://www.frantoioraguso.com/news_The_extra_virgin_olive_oil_ozonated_Pugliese__390.aspx> [retrieved on 20120222] * |
NEVEEN S.I., GEWEELY: "Antifungal activity of ozonized olive oil (oleozone)", INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY, 2006, pages 670 - 675, XP002666696 * |
PETROVIC Z S ET AL: "STRUCTURE AND PROPERTIES OF POLYURETHANES FROM TRIACYLGLYCERIDE POLYOLS BY OZONOLYSIS", BIOMACROMOLECULES, ACS, US, vol. 6, no. 2, 1 January 2005 (2005-01-01), pages 713 - 719, XP003015363, ISSN: 1525-7797, DOI: 10.1021/BM049451S * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014015290A1 (en) | 2012-07-19 | 2014-01-23 | P2 Science, Inc. | Ozonolysis operations for generation of reduced and/or oxidized product streams |
ITBA20120052A1 (en) * | 2012-09-06 | 2014-03-07 | Guerra Lorenzo | "DEVICE FOR THE GASIFICATION OF A LIPID MATRIX IN ENVIRONMENT AT A CONTROLLED TEMPERATURE" |
ITBA20130010A1 (en) * | 2013-02-13 | 2014-08-14 | Alice Biosources Srl | COMPOSITION FOR COSMETIC USE INCLUDING OLIVE OXIDE |
US9347014B2 (en) | 2013-04-03 | 2016-05-24 | Gfo Oil Llc | Methods and systems for generating aldehydes from organic seed oils |
ITMI20132112A1 (en) * | 2013-12-17 | 2015-06-18 | Pf S R L | COMPOSITION FOR THE TREATMENT OF MASTITIS IN COWS FROM MILK AND OVICAPRAPERS AND AN EQUIPMENT FOR THE PRODUCTION OF SUCH COMPOSITION. |
ITUB20155024A1 (en) * | 2015-11-24 | 2017-05-24 | Dario Apuzzo | New nutraceutical composition, which can be administered orally, for the prevention or treatment of inflammatory and painful states of the upper airway. |
ITUB20156007A1 (en) * | 2015-11-30 | 2017-05-30 | S I P R E S S R L | PROCEDURE FOR THE PRODUCTION OF OZONIZED NATURAL OILS AND OZONIZED NATURAL OIL MADE WITH THIS PROCEDURE |
ES2646335A1 (en) * | 2016-06-10 | 2017-12-13 | Nicolás RUBIO GARCÍA | Ozoneized oil with antioxidants (Machine-translation by Google Translate, not legally binding) |
IT201700037319A1 (en) * | 2017-04-05 | 2018-10-05 | Moss S P A | NATURAL COMPOSITION FOR USE IN GYNECOLOGY |
WO2018185676A1 (en) * | 2017-04-05 | 2018-10-11 | Moss S.P.A. | Natural composition for use in gynaecology |
US11369632B2 (en) | 2017-04-05 | 2022-06-28 | Organicare Llc | Natural composition for use in gynaecology |
US11857570B2 (en) | 2017-04-05 | 2024-01-02 | Organicare Llc | Natural composition for use in gynecology |
US11236289B2 (en) | 2017-11-22 | 2022-02-01 | Organicare, Llc | Method for the production of an ozonized olive oil |
WO2021105638A1 (en) | 2019-11-29 | 2021-06-03 | Demeta | Use of hydroperoxy alcohols and the derivatives thereof as antimicrobial agents |
EP3904327A1 (en) | 2020-04-30 | 2021-11-03 | Röhm GmbH | Method for the preparation of hydroxyalkyl-(meth) acrylic acid esters by oxidative cleavage of methacrolein acetals |
WO2021219409A1 (en) | 2020-04-30 | 2021-11-04 | Röhm Gmbh | Method for producing hydroxyalkyl(meth)acrylic acid esters by oxidative splitting of methacrolein acetals |
EP3949980A1 (en) | 2020-08-04 | 2022-02-09 | Vassiliki Griva | Compositions for the treatment of atopic dermatitis containing ozonated oils and natural antioxidant agents |
FR3123208A1 (en) * | 2021-06-01 | 2022-12-02 | Demeta | Cosmetic use of a hydroperoxyalcohol to fight against the cutaneous signs of aging |
Also Published As
Publication number | Publication date |
---|---|
ITMI20111045A1 (en) | 2012-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012168770A1 (en) | Process for ozonization of a vegetable oil | |
de Almeida et al. | Ozonized vegetable oils and therapeutic properties: A review. | |
KR101006693B1 (en) | Cosmetic compositions improving atopic dermatitis by complex function of damaged skin barrier repairing by lipid exchange and desensitizing, anti-inflammation and its manufacturing method thereof | |
LU88175A1 (en) | PHARMACEUTICAL PRODUCTS FOR CURING TUMOR DISEASES AND PROCESS FOR PREPARING THEM | |
EP3212288B1 (en) | Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract | |
JP2009504588A (en) | Composition of n-3 fatty acids having a high concentration of EPA and / or DHA and containing n-6 fatty acids | |
US8668944B2 (en) | Topical oil for treating physical ailments and method for making and applying the same | |
WO2019240713A2 (en) | Solutions comprising ozonized oil | |
KR20140071956A (en) | Composition for topical use based on ozonized oil | |
KR20080107279A (en) | A method for refining wood vinegar, refined wood vinegar thereby, and cosmetic, and mouth freshener containing the refined wood vinegar | |
DE102011055182A1 (en) | Anolyte, process for its preparation and its use | |
CN101559077A (en) | Gargle for relieving pain for oral inflammation disease | |
KR101866636B1 (en) | Composition for blood circulation comprising fermented ginger and mature ginger | |
CN105748358B (en) | A kind of agalloch eaglewood essence assigns running water and preparation method thereof | |
CN104430575A (en) | Disinfectant for disinfecting wards and preparation method of disinfectant for disinfecting wards | |
WO1996025409A1 (en) | Cosmetic or pharmaceutical compositions containing an ozonide-enriched natural vegetable oil, and uses thereof | |
JP2014088334A (en) | Athlete's foot medicine for external use | |
CN104206414B (en) | For cleaning thimerosal of red-light therapeutic instrument and preparation method thereof | |
CN108057350A (en) | A kind of solubilization method of ozone in tea oil | |
CN108018119A (en) | A kind of method that ozone is efficiently mutually mixed with vegetable oil | |
JPS6233123A (en) | Medicine for treating vital neoplastic phenomena and treating tumor, leukaemia and multiple-sclerosis and manufacture | |
CN109758562B (en) | Zedoary composite essential oil and preparation method and application thereof | |
US7261910B2 (en) | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use | |
Harada | Olive oil ozonide and its fungicidal quality | |
CN111888406A (en) | Chinese medicine preparation widely used for epidermic inflammation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11807992 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11807992 Country of ref document: EP Kind code of ref document: A1 |